Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 03, 2015 20:44 ET | Source: Mesoblast

Mesoblast Partner JCR Pharmaceuticals Receives Recommendation For Approval Of Mesenchymal Stem Cell Product In Japan

NEW YORK and MELBOURNE, Australia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced that the allogeneic mesenchymal stem cell-based regenerative medicine...
October 08, 2014 11:11 ET | Source: ARUP Laboratories

ARUP Laboratories and The Children's Hospital of Philadelphia Form Partnership to Offer High-resolution HLA genotyping by Next Generation Sequencing

SALT LAKE CITY, Oct. 8, 2014 (GLOBE NEWSWIRE) -- ARUP Laboratories announced today that they will be offering high-resolution HLA genotyping by next generation sequencing (NGS) under an agreement with...
April 28, 2014 21:51 ET | Source: Mesoblast

Mesoblast Provides Update on Clinical Programs of Prochymal for Crohn's Disease and Acute Graft Versus Host Disease

NEW YORK and MELBOURNE, Australia, April 28, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today provided an update on its clinical programs using the...
February 25, 2014 17:00 ET | Source: Mesoblast

Mesoblast Reports Strong Half-Year Financial Results

NEW YORK and MELBOURNE, Australia, Feb. 25, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today provided its 2014 half-year financial results and...
November 13, 2013 19:22 ET | Source: Mesoblast

IMPROVED SURVIVAL IN CHILDREN WITH LIFE THREATENING GRAFT VERSUS HOST DISEASE REPORTED AFTER TREATMENT WITH MESOBLAST'S CELL THERAPY

NEW YORK and MELBOURNE, Australia, Nov. 13, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced that a peer-reviewed article in the...